PharmaShots Weekly Snapshots (April 05 - 09, 2021)
Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug
Published: Apr 9, 2021 | Tags: Evotec and Exscientia, Initiate, Human Clinical Trials, Novel, Immuno-Oncology Drug
Published: Apr 9, 2021 | Tags: PlantForm, Signs, Research, Development Agreement, Bio-Manguinhos/Fiocruz, Develop, Biosimilar Pembrolizumab
Published: Apr 9, 2021 | Tags: BMS, Reports, Results, Opdivo (nivolumab), Yervoy (ipilimumab), P-III CheckMate -648 Trial, Unresectable, Advanced, Metastatic, ESCC
Published: Apr 9, 2021 | Tags: Merck, Report, Results, Keytruda (pembrolizumab), P-III KEYNOTE-564 Trial, Adjuvant, Treatment, Renal Cell Carcinoma
Hologic to Acquire Mobidiag for ~ $795M
Published: Apr 9, 2021 | Tags: Hologic, Acquire, Mobidiag, ~ $795M
Published: Apr 9, 2021 | Tags: Biogen, Signs, License, Commercialization, Agreement, Bio-Thera, BAT1806 (biosimilar, tocilizumab), Treat, Moderate, Severe, Rheumatoid Arthritis
Published: Apr 8, 2021 | Tags: Lilly and Incyte, Report, Results, Baricitinib, P-III COV-BARRIER Study, Hospitalized, Patients, COVID-19
Published: Apr 8, 2021 | Tags: Daiichi Sankyo, Reports, First, Patient, Dosing, P- I/II Trial, DS-1594, Treat, Acute, Myeloid Leukemia, Acute Lymphoblastic Leukemia
Published: Apr 8, 2021 | Tags: Merck KGaA, Selects, PRA, Remote Patient Monitoring Platform, Human Growth Hormone Treatment System
Published: Apr 8, 2021 | Tags: AbbVie, Submits, Regulatory Applications, US, FDA, EMA, Skyrizi (risankizumab), Treat, Psoriatic Arthritis
Published: Apr 8, 2021 | Tags: Biogen, Tysabri (natalizumab, SC), Receives, EC, Marketing Authorization, Treat, Relapsing-Remitting, Multiple Sclerosis
BMS and PsiOxus Therapeutics Expand their 2016 Immuno-Oncology Collaboration
Published: Apr 8, 2021 | Tags: BMS and PsiOxus Therapeutics, Expand, 2016, Immuno-Oncology Collaboration
Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies
Published: Apr 7, 2021 | Tags: Novartis, Collaborates, Artios Pharma, Discover, Next Generation, DDR Cancer Therapies
Published: Apr 7, 2021 | Tags: J&J Vision, Collaborates, Menicon, Offer, Contact Lenses, Managing, Progression, Myopia, Children
AstraZeneca Collaborates with MGH to Accelerate Digital Health Solutions
Published: Apr 7, 2021 | Tags: AstraZeneca, Collaborates, MGH, Accelerate, Digital Health Solutions
Published: Apr 7, 2021 | Tags: Progenity, Signs , Agreement, Ionis Pharmaceuticals, Evaluate, Oral Biotherapeutics Delivery System, Antisense Oligonucleotides
Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform
Published: Apr 7, 2021 | Tags: Pear, Sign, Multiple Agreements, Expands, Prescription Digital Therapeutic Platform
The US FDA Extends Review Period of Olumiant's sNDA to Treat Moderate to Severe Atopic Dermatitis
Published: Apr 7, 2021 | Tags: US, FDA, Extends, Review Period, Olumiant, sNDA, Treat, Moderate, Severe, Atopic Dermatitis
Passage Bio's PBKR03 Receives EC's Orphan Drug Designation for Krabbe Disease
Published: Apr 6, 2021 | Tags: Passage Bio, PBKR03, Receives, EC, Orphan Drug Designation, Krabbe Disease
Horizon Presents Results of Uplizna (inebilizumab-cdon) in N-MOmentum Trial for NMOSD at AAN 2021
Published: Apr 6, 2021 | Tags: Horizon, Presents ,Results, Uplizna (inebilizumab-cdon), N-MOmentum Trial, NMOSD
Exelixis Reports the US FDA's Acceptance of IND for XB002 in Patients with Advanced Solid Tumors
Published: Apr 6, 2021 | Tags: Exelixis, Reports, US, FDA, Acceptance, IND, XB002, Patients, Advanced, Solid Tumors
Published: Apr 6, 2021 | Tags: Ultragenyx, Collaborates, n-Lorem Foundation, Advance, Personalized, Medicines Treatment, Patients, Ultra-Rare Diseases
Welldoc Expands their Partnership with Dexcom to Offer Type 2 Diabetes Management Solution
Published: Apr 6, 2021 | Tags: Welldoc, Expands, Partnership, Dexcom, Offer, Type 2 Diabetes Management Solution
Sorrento to Acquire ACEA Therapeutics for ~$488M
Published: Apr 6, 2021 | Tags: Sorrento, Acquire, ACEA Therapeutics, ~$488M
Published: Apr 5, 2021 | Tags: uniQure, Reports, Completion, Enrollment, First, Cohort, P- I/II Trial, AMT-130, Treat, Huntington's Disease
mAbxience's MB02 (biosimilar, bevacizumab) Receives EC's Approval for the Treatment of Cancer
Published: Apr 5, 2021 | Tags: mAbxience, MB02 (biosimilar, bevacizumab), Receives, EC, Approval, Treatment, Cancer
Published: Apr 5, 2021 | Tags: Taiho Oncology, Futibatinib (TAS-120), Receives, US, FDA Breakthrough Therapy Designation, Advanced, Cholangiocarcinoma
Published: Apr 5, 2021 | Tags: Lilly, Taltz (ixekizumab), Receives, Health Canada, Approval, Pediatri Patient, Moderate, Severe, Plaque Psoriasis
Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications
Published: Apr 5, 2021 | Tags: Gilead, Expands, Collaboration, AbCellera, Develop, Antibodies, Against, Multiple Indications
Merck KGaA Exercises Third Option in its Immuno-Oncology Collaboration with F- star
Published: Apr 5, 2021 | Tags: Merck KGaA, Exercises, Third Option, Immuno-Oncology, Collaboration, F- star
Related Post: PharmaShots Weekly Snapshots (Mar 29 - Apr 02, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com